Part 1
Part 2
Part 3
Part 5
Description
The global market for Point-of-Care Diagnostics was estimated to be worth US$ 23310 million in 2023 and is forecast to a readjusted size of US$ 35370 million by 2030 with a CAGR of 5.7% during the forecast period 2024-2030 The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Point-of-Care Diagnostics Market Size
M= millions and B=billions
Report Scope
This report aims to provide a comprehensive presentation of the global market for Point-of-Care Diagnostics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Point-of-Care Diagnostics by region & country, by Type, and by Application.
The Point-of-Care Diagnostics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Point-of-Care Diagnostics.
Market Segmentation
Report Metric
Details
Report Title
Point-of-Care Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Forecasted Market Size in 2030
US$ 35370 million
CAGR(2024-2030)
5.7%
Market Size Available for Years
2019-2030
Global Point-of-Care Diagnostics Companies Covered
Abaxis, Abbott, Bayer, Danaher Corporation, Becton Dickinson, Johnson & Johnson, Nipro, Roche Diagnostics, Siemens, Samsung Medison
Global Point-of-Care Diagnostics Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Point-of-Care Diagnostics Market, Segment by Type
Glucose Monitoring Kits
Infectious Diseases Testing Kits
Cardiometabolic Monitoring Kits
Coagulation Monitoring Kits
Hematology Testing Kits
Urinalysis Testing Kits
Cholesterol Test Strips
Drugs-Of-Abuse Testing Kits
Tumor/Cancer Markers
Other
Global Point-of-Care Diagnostics Market, Segment by Application
Home
Hospitals
Ambulatory Care
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Point-of-Care Diagnostics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Point-of-Care Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Point-of-Care Diagnostics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Point-of-Care Diagnostics Product Introduction
1.2 Global Point-of-Care Diagnostics Market Size Forecast
1.3 Point-of-Care Diagnostics Market Trends & Drivers
1.3.1 Point-of-Care Diagnostics Industry Trends
1.3.2 Point-of-Care Diagnostics Market Drivers & Opportunity
1.3.3 Point-of-Care Diagnostics Market Challenges
1.3.4 Point-of-Care Diagnostics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Point-of-Care Diagnostics Players Revenue Ranking (2023)
2.2 Global Point-of-Care Diagnostics Revenue by Company (2019-2024)
2.3 Key Companies Point-of-Care Diagnostics Manufacturing Base Distribution and Headquarters
2.4 Key Companies Point-of-Care Diagnostics Product Offered
2.5 Key Companies Time to Begin Mass Production of Point-of-Care Diagnostics
2.6 Point-of-Care Diagnostics Market Competitive Analysis
2.6.1 Point-of-Care Diagnostics Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Point-of-Care Diagnostics Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-Care Diagnostics as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Glucose Monitoring Kits
3.1.2 Infectious Diseases Testing Kits
3.1.3 Cardiometabolic Monitoring Kits
3.1.4 Coagulation Monitoring Kits
3.1.5 Hematology Testing Kits
3.1.6 Urinalysis Testing Kits
3.1.7 Cholesterol Test Strips
3.1.8 Drugs-Of-Abuse Testing Kits
3.1.9 Tumor/Cancer Markers
3.1.10 Other
3.2 Global Point-of-Care Diagnostics Sales Value by Type
3.2.1 Global Point-of-Care Diagnostics Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Point-of-Care Diagnostics Sales Value, by Type (2019-2030)
3.2.3 Global Point-of-Care Diagnostics Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Home
4.1.2 Hospitals
4.1.3 Ambulatory Care
4.2 Global Point-of-Care Diagnostics Sales Value by Application
4.2.1 Global Point-of-Care Diagnostics Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Point-of-Care Diagnostics Sales Value, by Application (2019-2030)
4.2.3 Global Point-of-Care Diagnostics Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Point-of-Care Diagnostics Sales Value by Region
5.1.1 Global Point-of-Care Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Point-of-Care Diagnostics Sales Value by Region (2019-2024)
5.1.3 Global Point-of-Care Diagnostics Sales Value by Region (2025-2030)
5.1.4 Global Point-of-Care Diagnostics Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Point-of-Care Diagnostics Sales Value, 2019-2030
5.2.2 North America Point-of-Care Diagnostics Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Point-of-Care Diagnostics Sales Value, 2019-2030
5.3.2 Europe Point-of-Care Diagnostics Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Point-of-Care Diagnostics Sales Value, 2019-2030
5.4.2 Asia Pacific Point-of-Care Diagnostics Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Point-of-Care Diagnostics Sales Value, 2019-2030
5.5.2 South America Point-of-Care Diagnostics Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Point-of-Care Diagnostics Sales Value, 2019-2030
5.6.2 Middle East & Africa Point-of-Care Diagnostics Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Point-of-Care Diagnostics Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Point-of-Care Diagnostics Sales Value
6.3 United States
6.3.1 United States Point-of-Care Diagnostics Sales Value, 2019-2030
6.3.2 United States Point-of-Care Diagnostics Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Point-of-Care Diagnostics Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Point-of-Care Diagnostics Sales Value, 2019-2030
6.4.2 Europe Point-of-Care Diagnostics Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Point-of-Care Diagnostics Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Point-of-Care Diagnostics Sales Value, 2019-2030
6.5.2 China Point-of-Care Diagnostics Sales Value by Type (%), 2023 VS 2030
6.5.3 China Point-of-Care Diagnostics Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Point-of-Care Diagnostics Sales Value, 2019-2030
6.6.2 Japan Point-of-Care Diagnostics Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Point-of-Care Diagnostics Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Point-of-Care Diagnostics Sales Value, 2019-2030
6.7.2 South Korea Point-of-Care Diagnostics Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Point-of-Care Diagnostics Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Point-of-Care Diagnostics Sales Value, 2019-2030
6.8.2 Southeast Asia Point-of-Care Diagnostics Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Point-of-Care Diagnostics Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Point-of-Care Diagnostics Sales Value, 2019-2030
6.9.2 India Point-of-Care Diagnostics Sales Value by Type (%), 2023 VS 2030
6.9.3 India Point-of-Care Diagnostics Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abaxis
7.1.1 Abaxis Profile
7.1.2 Abaxis Main Business
7.1.3 Abaxis Point-of-Care Diagnostics Products, Services and Solutions
7.1.4 Abaxis Point-of-Care Diagnostics Revenue (US$ Million) & (2019-2024)
7.1.5 Abaxis Recent Developments
7.2 Abbott
7.2.1 Abbott Profile
7.2.2 Abbott Main Business
7.2.3 Abbott Point-of-Care Diagnostics Products, Services and Solutions
7.2.4 Abbott Point-of-Care Diagnostics Revenue (US$ Million) & (2019-2024)
7.2.5 Abbott Recent Developments
7.3 Bayer
7.3.1 Bayer Profile
7.3.2 Bayer Main Business
7.3.3 Bayer Point-of-Care Diagnostics Products, Services and Solutions
7.3.4 Bayer Point-of-Care Diagnostics Revenue (US$ Million) & (2019-2024)
7.3.5 Danaher Corporation Recent Developments
7.4 Danaher Corporation
7.4.1 Danaher Corporation Profile
7.4.2 Danaher Corporation Main Business
7.4.3 Danaher Corporation Point-of-Care Diagnostics Products, Services and Solutions
7.4.4 Danaher Corporation Point-of-Care Diagnostics Revenue (US$ Million) & (2019-2024)
7.4.5 Danaher Corporation Recent Developments
7.5 Becton Dickinson
7.5.1 Becton Dickinson Profile
7.5.2 Becton Dickinson Main Business
7.5.3 Becton Dickinson Point-of-Care Diagnostics Products, Services and Solutions
7.5.4 Becton Dickinson Point-of-Care Diagnostics Revenue (US$ Million) & (2019-2024)
7.5.5 Becton Dickinson Recent Developments
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Profile
7.6.2 Johnson & Johnson Main Business
7.6.3 Johnson & Johnson Point-of-Care Diagnostics Products, Services and Solutions
7.6.4 Johnson & Johnson Point-of-Care Diagnostics Revenue (US$ Million) & (2019-2024)
7.6.5 Johnson & Johnson Recent Developments
7.7 Nipro
7.7.1 Nipro Profile
7.7.2 Nipro Main Business
7.7.3 Nipro Point-of-Care Diagnostics Products, Services and Solutions
7.7.4 Nipro Point-of-Care Diagnostics Revenue (US$ Million) & (2019-2024)
7.7.5 Nipro Recent Developments
7.8 Roche Diagnostics
7.8.1 Roche Diagnostics Profile
7.8.2 Roche Diagnostics Main Business
7.8.3 Roche Diagnostics Point-of-Care Diagnostics Products, Services and Solutions
7.8.4 Roche Diagnostics Point-of-Care Diagnostics Revenue (US$ Million) & (2019-2024)
7.8.5 Roche Diagnostics Recent Developments
7.9 Siemens
7.9.1 Siemens Profile
7.9.2 Siemens Main Business
7.9.3 Siemens Point-of-Care Diagnostics Products, Services and Solutions
7.9.4 Siemens Point-of-Care Diagnostics Revenue (US$ Million) & (2019-2024)
7.9.5 Siemens Recent Developments
7.10 Samsung Medison
7.10.1 Samsung Medison Profile
7.10.2 Samsung Medison Main Business
7.10.3 Samsung Medison Point-of-Care Diagnostics Products, Services and Solutions
7.10.4 Samsung Medison Point-of-Care Diagnostics Revenue (US$ Million) & (2019-2024)
7.10.5 Samsung Medison Recent Developments
8 Industry Chain Analysis
8.1 Point-of-Care Diagnostics Industrial Chain
8.2 Point-of-Care Diagnostics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Point-of-Care Diagnostics Sales Model
8.5.2 Sales Channel
8.5.3 Point-of-Care Diagnostics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. Point-of-Care Diagnostics Market Trends
Table 2. Point-of-Care Diagnostics Market Drivers & Opportunity
Table 3. Point-of-Care Diagnostics Market Challenges
Table 4. Point-of-Care Diagnostics Market Restraints
Table 5. Global Point-of-Care Diagnostics Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Point-of-Care Diagnostics Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Point-of-Care Diagnostics Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Point-of-Care Diagnostics Product Type
Table 9. Key Companies Time to Begin Mass Production of Point-of-Care Diagnostics
Table 10. Global Point-of-Care Diagnostics Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-Care Diagnostics as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Point-of-Care Diagnostics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Point-of-Care Diagnostics Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Point-of-Care Diagnostics Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Point-of-Care Diagnostics Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Point-of-Care Diagnostics Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Point-of-Care Diagnostics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Point-of-Care Diagnostics Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Point-of-Care Diagnostics Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Point-of-Care Diagnostics Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Point-of-Care Diagnostics Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Point-of-Care Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Point-of-Care Diagnostics Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Point-of-Care Diagnostics Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Point-of-Care Diagnostics Sales Value by Region (2019-2024) & (%)
Table 27. Global Point-of-Care Diagnostics Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Point-of-Care Diagnostics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Point-of-Care Diagnostics Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Point-of-Care Diagnostics Sales Value, (2025-2030) & (US$ Million)
Table 31. Abaxis Basic Information List
Table 32. Abaxis Description and Business Overview
Table 33. Abaxis Point-of-Care Diagnostics Products, Services and Solutions
Table 34. Revenue (US$ Million) in Point-of-Care Diagnostics Business of Abaxis (2019-2024)
Table 35. Abaxis Recent Developments
Table 36. Abbott Basic Information List
Table 37. Abbott Description and Business Overview
Table 38. Abbott Point-of-Care Diagnostics Products, Services and Solutions
Table 39. Revenue (US$ Million) in Point-of-Care Diagnostics Business of Abbott (2019-2024)
Table 40. Abbott Recent Developments
Table 41. Bayer Basic Information List
Table 42. Bayer Description and Business Overview
Table 43. Bayer Point-of-Care Diagnostics Products, Services and Solutions
Table 44. Revenue (US$ Million) in Point-of-Care Diagnostics Business of Bayer (2019-2024)
Table 45. Bayer Recent Developments
Table 46. Danaher Corporation Basic Information List
Table 47. Danaher Corporation Description and Business Overview
Table 48. Danaher Corporation Point-of-Care Diagnostics Products, Services and Solutions
Table 49. Revenue (US$ Million) in Point-of-Care Diagnostics Business of Danaher Corporation (2019-2024)
Table 50. Danaher Corporation Recent Developments
Table 51. Becton Dickinson Basic Information List
Table 52. Becton Dickinson Description and Business Overview
Table 53. Becton Dickinson Point-of-Care Diagnostics Products, Services and Solutions
Table 54. Revenue (US$ Million) in Point-of-Care Diagnostics Business of Becton Dickinson (2019-2024)
Table 55. Becton Dickinson Recent Developments
Table 56. Johnson & Johnson Basic Information List
Table 57. Johnson & Johnson Description and Business Overview
Table 58. Johnson & Johnson Point-of-Care Diagnostics Products, Services and Solutions
Table 59. Revenue (US$ Million) in Point-of-Care Diagnostics Business of Johnson & Johnson (2019-2024)
Table 60. Johnson & Johnson Recent Developments
Table 61. Nipro Basic Information List
Table 62. Nipro Description and Business Overview
Table 63. Nipro Point-of-Care Diagnostics Products, Services and Solutions
Table 64. Revenue (US$ Million) in Point-of-Care Diagnostics Business of Nipro (2019-2024)
Table 65. Nipro Recent Developments
Table 66. Roche Diagnostics Basic Information List
Table 67. Roche Diagnostics Description and Business Overview
Table 68. Roche Diagnostics Point-of-Care Diagnostics Products, Services and Solutions
Table 69. Revenue (US$ Million) in Point-of-Care Diagnostics Business of Roche Diagnostics (2019-2024)
Table 70. Roche Diagnostics Recent Developments
Table 71. Siemens Basic Information List
Table 72. Siemens Description and Business Overview
Table 73. Siemens Point-of-Care Diagnostics Products, Services and Solutions
Table 74. Revenue (US$ Million) in Point-of-Care Diagnostics Business of Siemens (2019-2024)
Table 75. Siemens Recent Developments
Table 76. Samsung Medison Basic Information List
Table 77. Samsung Medison Description and Business Overview
Table 78. Samsung Medison Point-of-Care Diagnostics Products, Services and Solutions
Table 79. Revenue (US$ Million) in Point-of-Care Diagnostics Business of Samsung Medison (2019-2024)
Table 80. Samsung Medison Recent Developments
Table 81. Key Raw Materials Lists
Table 82. Raw Materials Key Suppliers Lists
Table 83. Point-of-Care Diagnostics Downstream Customers
Table 84. Point-of-Care Diagnostics Distributors List
Table 85. Research Programs/Design for This Report
Table 86. Key Data Information from Secondary Sources
Table 87. Key Data Information from Primary Sources
Table 88. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Point-of-Care Diagnostics Product Picture
Figure 2. Global Point-of-Care Diagnostics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Point-of-Care Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 4. Point-of-Care Diagnostics Report Years Considered
Figure 5. Global Point-of-Care Diagnostics Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Point-of-Care Diagnostics Revenue in 2023
Figure 7. Point-of-Care Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Glucose Monitoring Kits Picture
Figure 9. Infectious Diseases Testing Kits Picture
Figure 10. Cardiometabolic Monitoring Kits Picture
Figure 11. Coagulation Monitoring Kits Picture
Figure 12. Hematology Testing Kits Picture
Figure 13. Urinalysis Testing Kits Picture
Figure 14. Cholesterol Test Strips Picture
Figure 15. Drugs-Of-Abuse Testing Kits Picture
Figure 16. Tumor/Cancer Markers Picture
Figure 17. Other Picture
Figure 18. Global Point-of-Care Diagnostics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Point-of-Care Diagnostics Sales Value Market Share by Type, 2023 & 2030
Figure 20. Product Picture of Home
Figure 21. Product Picture of Hospitals
Figure 22. Product Picture of Ambulatory Care
Figure 23. Global Point-of-Care Diagnostics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 24. Global Point-of-Care Diagnostics Sales Value Market Share by Application, 2023 & 2030
Figure 25. North America Point-of-Care Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 26. North America Point-of-Care Diagnostics Sales Value by Country (%), 2023 VS 2030
Figure 27. Europe Point-of-Care Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 28. Europe Point-of-Care Diagnostics Sales Value by Country (%), 2023 VS 2030
Figure 29. Asia Pacific Point-of-Care Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 30. Asia Pacific Point-of-Care Diagnostics Sales Value by Country (%), 2023 VS 2030
Figure 31. South America Point-of-Care Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 32. South America Point-of-Care Diagnostics Sales Value by Country (%), 2023 VS 2030
Figure 33. Middle East & Africa Point-of-Care Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 34. Middle East & Africa Point-of-Care Diagnostics Sales Value by Country (%), 2023 VS 2030
Figure 35. Key Countries/Regions Point-of-Care Diagnostics Sales Value (%), (2019-2030)
Figure 36. United States Point-of-Care Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 37. United States Point-of-Care Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 38. United States Point-of-Care Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 39. Europe Point-of-Care Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 40. Europe Point-of-Care Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 41. Europe Point-of-Care Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 42. China Point-of-Care Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 43. China Point-of-Care Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 44. China Point-of-Care Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 45. Japan Point-of-Care Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 46. Japan Point-of-Care Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 47. Japan Point-of-Care Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 48. South Korea Point-of-Care Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 49. South Korea Point-of-Care Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 50. South Korea Point-of-Care Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 51. Southeast Asia Point-of-Care Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 52. Southeast Asia Point-of-Care Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 53. Southeast Asia Point-of-Care Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 54. India Point-of-Care Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 55. India Point-of-Care Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 56. India Point-of-Care Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 57. Point-of-Care Diagnostics Industrial Chain
Figure 58. Point-of-Care Diagnostics Manufacturing Cost Structure
Figure 59. Channels of Distribution (Direct Sales, and Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Description
The global market for Point-of-Care Diagnostics was estimated to be worth US$ 23310 million in 2023 and is forecast to a readjusted size of US$ 35370 million by 2030 with a CAGR of 5.7% during the forecast period 2024-2030 The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Point-of-Care Diagnostics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Point-of-Care Diagnostics by region & country, by Type, and by Application.
The Point-of-Care Diagnostics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Point-of-Care Diagnostics.
Market Segmentation
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Point-of-Care Diagnostics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Point-of-Care Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Point-of-Care Diagnostics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
English
Simon Lee
English
Hitesh
Chinese
Damon
Japanese
Tang Xin
Korean
Sung-Bin Yoon
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 18 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database
English
Simon Lee
English
Hitesh
Chinese
Damon
Japanese
Tang Xin
Korean
Sung-Bin Yoon
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 18 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database
Add to Cart
Buy Now